Europe
Clinical News
Informatics
Industry News
Practice Management
Education
Subspecialties
More
Sign In
CT
Digital X-Ray
Interventional
Molecular Imaging
MRI
Radiation Oncology/Therapy
Ultrasound
Womens Imaging
Molecular Imaging: Page 120
Navidea touts phase IIB study looking at RA
By
AuntMinnie.com staff writers
Radiopharmaceutical developer Navidea Biopharmaceuticals said that interim data from its phase IIB study for technetium-99m tilmanocept in patients with rheumatoid arthritis (RA) shows that the radiopharmaceutical provides quantitative imaging in healthy controls as well as in patients with active RA.
May 21, 2020
ARTMS raises $19M in funding round
By
AuntMinnie.com staff writers
Medical isotope developer ARTMS has raised $19Â million in a series A round of financing with two investment funds.
May 20, 2020
DocPanel picks MIM software
By
AuntMinnie.com staff writers
Medical imaging software developer MIM Software announced that DocPanel has added MIM's nuclear medicine software to its oncology imaging marketplace.
May 18, 2020
SPECT agent could help spot DNA damage from radiotherapy
By
Wayne Forrest
Researchers from the U.K. may have developed a way to observe in vivo DNA damage a few days after treatment for neuroendocrine tumors with lutetium-177-DOTATATE, according to a proof-of-concept preclinical study published in the May issue of the
Journal of Nuclear Medicine
.
May 18, 2020
Blue Earth highlights PET agent clinical results
By
AuntMinnie.com staff writers
Bracco molecular imaging subsidiary Blue Earth Diagnostics is highlighting clinical results from a German study using PET/CT and its radiohybrid prostate-specific membrane antigen-targeted compound for prostate cancer.
May 18, 2020
New PET/CT tracer reliably detects prostate cancer
By
Wayne Forrest
Nuclear medicine departments now have a second reliable radiopharmaceutical to consider with PET/CT when staging for prostate cancer, according to a study in the April issue of the
Journal of Nuclear Medicine
.
May 12, 2020
New PET technique visualizes early Alzheimer's disease
By
Kate Madden Yee
A new PET technique can visualize early Alzheimer's disease by imaging the synaptic density of the brain as indicated by the presence of a particular protein, according to a study by researchers from Yale University that was published May 13 in the
Alzheimer's & Dementia Journal
.
May 12, 2020
MITA joins coalition to lobby for COVID-19 relief
By
AuntMinnie.com staff writers
The Medical Imaging and Technology Alliance (MITA) has joined with a number of imaging organizations to lobby congressional leaders for direct financial support to radiology providers to be included in the next COVID-19 legislative relief package.
May 11, 2020
PET tracer could more precisely diagnose Alzheimer's
By
Wayne Forrest
A new PET tracer called RO-948 could become the standard method for diagnosing Alzheimer's disease, accurately differentiating the condition from other neurodegenerative diseases, according to a study published May 11 in
JAMA Neurology
.
May 11, 2020
Companies partner on gallium-68 imaging
By
AuntMinnie.com staff writers
ARTMS Products and Telix Pharmaceuticals have signed a partnership covering the manufacturing of a radiopharmaceutical-based imaging agent based on the gallium-68 isotope.
May 5, 2020
MRI offers kids radiation-free chemo response tracking
By
Kate Madden Yee
Whole-body diffusion-weighted MRI appears to help clinicians effectively assess tumor response to chemotherapy in children, according to a study published May 5 in
Radiology
.
May 4, 2020
MILabs remotely installs Vector system in Japan
By
AuntMinnie.com staff writers
Preclinical imaging developer MILabs from the Netherlands remotely installed one of its E-class Vector 6 PET/SPECT/CT systems at the Osaka University of Pharmaceutical Sciences in Japan.
May 4, 2020
Previous Page
Page 120 of 614
Next Page
